Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease

Lessa, 2015, Burden of Clostridium difficile infection in the United States, N. Engl. J. Med., 372, 825, 10.1056/NEJMoa1408913 Zimlichman, 2013, Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system, JAMA Intern Med, 173, 2039, 10.1001/jamainternmed.2013.9763 Zhang, 2018, Attributable healthcare resource utilization and costs for patients with primary and recurrent Clostridium difficile infection in the United States, Clin. Infect. Dis., 10.1093/cid/cix1021 Johnson, 2009, Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes, J. Infect., 58, 403, 10.1016/j.jinf.2009.03.010 Kyne, 2001, Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea, Lancet, 357, 189, 10.1016/S0140-6736(00)03592-3 Seekatz, 2016, Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection, Genome Med., 8, 1, 10.1186/s13073-016-0298-8 McDonald, 2005, An epidemic, toxin gene-variant strain of Clostridium difficile, N. Engl. J. Med., 353, 2433, 10.1056/NEJMoa051590 Petrella, 2012, Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain, Clin. Infect. Dis., 55, 351, 10.1093/cid/cis430 Crobach, 2017, An outbreak of Clostridium difficile infections due to new PCR ribotype 826: epidemiologic and microbiologic analyses, Clin. Microbiol. Infect. Fawley, 2016, Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013, Euro Surveill., 21, 10.2807/1560-7917.ES.2016.21.29.30295 Johnson, 1989, Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism, J. Infect. Dis., 159, 340, 10.1093/infdis/159.2.340 Eyre, 2012, Clostridium difficile mixed infection and reinfection, J. Clin. Microbiol., 50, 142, 10.1128/JCM.05177-11 Oka, 2012, Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases, J. Clin. Microbiol., 50, 915, 10.1128/JCM.05588-11 Behroozian, 2013, Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping, Infect. Control Hosp. Epidemiol., 34, 961, 10.1086/671728 Rao, 2015, Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality, Clin. Infect. Dis., 61, 233, 10.1093/cid/civ254 Cohen, 2010, Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA), Infect. Control Hosp. Epidemiol., 31, 431, 10.1086/651706 McDonald, 2007, Recommendations for surveillance of Clostridium difficile-associated disease, Infect. Control Hosp. Epidemiol., 28, 140, 10.1086/511798 Martinson, 2015, Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology, J. Clin. Microbiol., 53, 1192, 10.1128/JCM.03591-14 Wickham, 2017 Wickham, 2009 Brunson, 2018 Hojsgaard, 2014 Abou Chakra, 2014, Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review, PLoS One, 9, 10.1371/journal.pone.0098400 Wilcox, 2017, Bezlotoxumab for prevention of recurrent Clostridium difficile infection, N. Engl. J. Med., 376, 305, 10.1056/NEJMoa1602615 Shen, 2017, Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: a systematic review with meta-regression analysis, Gastroenterology, 152, 1889, 10.1053/j.gastro.2017.02.003 Crook, 2012, Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials, Clin. Infect. Dis., 55, S93, 10.1093/cid/cis499 McDonald, 2018, Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA), Clin. Infect. Dis., 10.1093/cid/ciy149 van den Berg, 2005, Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies, J. Med. Microbiol., 54, 173, 10.1099/jmm.0.45825-0 Wroblewski, 2009, Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens, J. Clin. Microbiol., 47, 2142, 10.1128/JCM.02498-08 Chitnis, 2013, Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011, JAMA Intern Med, 173, 1359, 10.1001/jamainternmed.2013.7056 Eyre, 2014, Diverse sources of C. difficile infection, N. Engl. J. Med., 370, 183 Kamboj, 2011, Relapse versus reinfection: surveillance of Clostridium difficile infection, Clin. Infect. Dis., 53, 1003, 10.1093/cid/cir643 Wilcox, 1998, Recurrence of symptoms in Clostridium difficile infection–relapse or reinfection?, J. Hosp. Infect., 38, 93, 10.1016/S0195-6701(98)90062-7 Figueroa, 2012, Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin, Clin. Infect. Dis., 55, S104, 10.1093/cid/cis357